Sector Expert: Joanne Wuensch
Joanne Wuensch is a research analyst in the equity research group of BMO Capital Markets Corp., where she covers medical technology companies in the cardiology, ophthalmology, orthopedic and respiratory sectors. Before joining BMO Capital Markets, Wuensch was a research analyst with ABN Amro, where she covered medical products, and was a research associate in the medical technology group at UBS Securities. Her career in financial services began at J.P. Morgan, where, among other positions, she was an associate in municipal finance investment banking in the health care and higher education group. Wuensch joined BMO Capital Markets in 2002. She holds an Masters in Public Administration from New York University and a Bachelor of Arts from the University of Delaware.
Medical technology has been stalled in a quagmire of regulation, lowered usage and a more tight-fisted health insurance environment, but Analyst and Managing Director Joanne Wuensch of BMO Capital Markets has identified a few ground-breaking technologies that will drive increasing cash flows in particular companies. In this exclusive interview with The Life Sciences Report, Wuensch delivers the names that will provide essential diversification while they return growth for investors.
"JNJ's Q112 orthopedic sales reflected stability in that market."
Joanne Wuensch, BMO Capital Markets
"I'm bullish on MDT, which I've rated Outperform."
The Life Sciences Report Interview with Joanne Wuensch